Request Demo
Last update 01 Nov 2025
ILB-2109
Last update 01 Nov 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ILB 2109, ILB2109, WTS-001 |
Target |
Action antagonists |
Mechanism A2aR antagonists(Adenosine A2a receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with ILB-2109NCT05955105
A Phase Ib/IIa, Multicenter, Open-label Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
NCT05278546
A Phase Ia, Multicenter, Open-label Study of ILB2109 in Patients With Advanced Solid Malignancies
100 Clinical Results associated with ILB-2109
Login to view more data
100 Translational Medicine associated with ILB-2109
Login to view more data
100 Patents (Medical) associated with ILB-2109
Login to view more data
100 Deals associated with ILB-2109
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 25 Jul 2023 | |
| Classical Hodgkin's Lymphoma | Phase 2 | China | 25 Jul 2023 | |
| Endometrial Carcinoma | Phase 2 | China | 25 Jul 2023 | |
| Melanoma | Phase 2 | China | 25 Jul 2023 | |
| Nasopharyngeal Carcinoma | Phase 2 | China | 25 Jul 2023 | |
| Non-Small Cell Lung Cancer | Phase 2 | China | 25 Jul 2023 | |
| Ovarian Cancer | Phase 2 | China | 25 Jul 2023 | |
| Soft Tissue Sarcoma | Phase 2 | China | 25 Jul 2023 | |
| Triple Negative Breast Cancer | Phase 2 | China | 25 Jul 2023 | |
| Uterine Cervical Cancer | Phase 2 | China | 25 Jul 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free